Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol (December 13, 2006). doi:10.1152/ajpcell.00258.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/C1714    most recent
00258.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahn, H. S.
Right arrow Articles by Hahn, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahn, H. S.
Right arrow Articles by Hahn, S. J.
Submitted on May 11, 2006
Accepted on December 11, 2006

Calcineurin-independent inhibition of Kv1.3 by FK-506 (Tacrolimus): A novel pharmacological property

Hye Sook Ahn1, Sung Eun Kim2, Bok Hee Choi3, Jin-Sung Choi2, Myung-Jun Kim2, Duck-Joo Rhie2, Shin Hee Yoon2, Yang-Hyeok Jo2, Myung-Suk Kim2, Ki-Wug Sung4, Oh-Joo Kwon5, and Sang June Hahn2*

1 Physiology, The Catholic University of Korea, Seoul, Korea, Republic of
2 Physiology, The Catholic University of Korea, Seoul, Korea, Republic of; Seoul, Korea, Republic of
3 Pharmacology, Chonbuk National University, Jeonju, Korea, Republic of
4 Pharmacology, The Catholic University of Korea, Seoul, Korea, Republic of
5 Biochemistry, The Catholic University of Korea, Seoul, Korea, Republic of

* To whom correspondence should be addressed. E-mail: sjhahn{at}catholic.ac.kr.

The interaction of FK-506 with Kv1.3, stably expressed in CHO cells, was investigated using the whole-cell patch-clamp technique. FK-506 inhibited Kv1.3 in a reversible, concentration-dependent manner with an IC50 of 5.6 µM. Rapamycin, another immunosuppressant, produced effects that were similar to those of FK-506 (IC50 = 6.7 µM). Other calcineurin inhibitors (cypermethrin or calcineurin autoinhibitory peptide) alone had no effect on the amplitude or kinetics of Kv1.3. In addition, the inhibitory action of FK-506 continued, even after the inhibition of the calcineurin activity. The inhibition produced by FK-506 was voltage-dependent, increasing in the voltage range for channel activation. At potential positive to 0 mV (where maximal conductance is reached), however, no voltage-dependent inhibition was found. FK-506 exhibited a strong use-dependent inhibition of Kv1.3. FK-506 shifted the steady-state inactivation curves of Kv1.3 in the hyperpolarizing direction in a concentration-dependent manner. The apparent dissociation constant (Ki) for FK-506 to inhibit Kv1.3 in the inactivated state was estimated from the concentration-dependent shift in the steady-state inactivation curve and was calculated to be 0.37 µM. Moreover, the rate of recovery from inactivation of Kv1.3 was decreased. In inside-out patches, FK-506 not only reduced the current amplitude but also accelerated the rate of inactivation during depolarization. FK-506 also inhibited Kv1.5 and Kv4.3 in a concentration-dependent manner with an IC50 of 4.6 and 53.9 µM, respectively. The present results indicate that FK-506 inhibits Kv1.3 directly and that this effect is not mediated via the inhibition of the phosphatase activity of calcineurin.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.